NCT05882071View on ClinicalTrials.gov

Non-interventional Study (NIS) on Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Use in France

Active, not recruitingOBSERVATIONAL
Enrollment

547,150

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Sodium/glucose cotransporter-2 inhibitors (SGLT2i)

Sodium/glucose cotransporter-2 inhibitors (SGLT2i)

Trial Locations (1)

75013

Boehringer Ingelheim, Paris

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05882071 - Non-interventional Study (NIS) on Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Use in France | Biotech Hunter | Biotech Hunter